NICE backs new drugs for Crohn's disease, lymphoma Eli Lilly's Omvoh has been recommended for use in Crohn's disease by NICE, while BeOne's Brukinsa gets the go-ahead for mantle cell lymphoma.

#NICE #EliLilly #Omvoh #Crohnsdisease #BeOneMedicine #Brukinsa #mantlecelllymphoma #ulcerativecolitis #NICEguidance #gastroenterology #SMC #Brukinsa #relapsedMCL #refractoryMCL #Waldenstromsmacroglobulinaemia #chroniclymphocyticleukaemia #marginalzonelymphoma
pharmaphorum.com/news/nice-ba...